Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors-Reference-Cited by-同舟云学术

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

Published:2012-07 Issue:7408 Volume:487 Page:505-509
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Wilson Timothy R.,Fridlyand Jane,Yan Yibing,Penuel Elicia,Burton Luciana,Chan Emily,Peng Jing,Lin Eva,Wang Yulei,Sosman Jeff,Ribas Antoni,Li Jiang,Moffat John,Sutherlin Daniel P.,Koeppen Hartmut,Merchant Mark,Neve Richard,Settleman Jeff

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature11249.pdf

Reference29 articles.

1. Sharma, S. V. & Settleman, J. Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev. 21, 3214–3231 (2007)

2. Sequist, L. V. et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci. Transl. Med. 3, 75ra26 (2011)

3. Garrett, J. T. & Arteaga, C. L. Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: mechanisms and clinical implications. Cancer Biol. Ther. 11, 793–800 (2011)

4. Engelman, J. A. & Settleman, J. Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Curr. Opin. Genet. Dev. 18, 73–79 (2008)

5. Moritz, A. et al. Akt–RSK–S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci. Signal. 3, ra64 (2010)

Cited by 1001 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Blood Serum Antagonizes Effects of EGFR/HER2-Targeted Drug Lapatinib on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Биохимия;2024-09-14

2. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

3. Cancer-associated fibroblasts confer ALK inhibitor resistance inEML4-ALK-driven lung cancer via concurrent integrin and MET signaling;2024-08-28

4. Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy;Journal of Experimental & Clinical Cancer Research;2024-08-15

5. Dissecting the Spatially Restricted Effects of Microenvironment-Mediated Resistance on Targeted Therapy Responses;Cancers;2024-06-29